155 related articles for article (PubMed ID: 4274674)
1. Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
Tobin T; Akera T; Ku D; Lu MC
Mol Pharmacol; 1973 Sep; 9(5):676-85. PubMed ID: 4274674
[No Abstract] [Full Text] [Related]
2. The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+,K+-adenosine triphosphatase interaction.
Wallick ET; Dowd F; Allen JC; Schwartz A
J Pharmacol Exp Ther; 1974 May; 189(2):434-44. PubMed ID: 4275234
[No Abstract] [Full Text] [Related]
3. Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.
Albers RW; Koval GJ; Siegel
Mol Pharmacol; 1968 Jul; 4(4):324-36. PubMed ID: 4232893
[No Abstract] [Full Text] [Related]
4. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
Yoda A; Yoda S
Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
[No Abstract] [Full Text] [Related]
5. Structue-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate.
Yoda A
Mol Pharmacol; 1973 Jan; 9(1):51-60. PubMed ID: 4265446
[No Abstract] [Full Text] [Related]
6. Inhibition of calf brain membranal sodium- and potassium-dependent adenosine triphosphatase by cardioactive sterols. A binding site model.
Wilson WE; Sivitz WI; Hanna LT
Mol Pharmacol; 1970 Sep; 6(5):449-59. PubMed ID: 4248266
[No Abstract] [Full Text] [Related]
7. Inhibitory sites on sodium- and potassium-activated adenosine triphosphatase for chlorpromazine free radical and ouabain.
Akera T; Brody TM
Mol Pharmacol; 1970 Sep; 6(5):557-66. PubMed ID: 4248267
[No Abstract] [Full Text] [Related]
8. Effects of inhibitors of (Na plus, plus, K plus)-dependent adenosine triphosphatase on the uptake of norepinephrne by synaptosomes.
White TD; Keen P
Mol Pharmacol; 1971 Jan; 7(1):40-5. PubMed ID: 4251728
[No Abstract] [Full Text] [Related]
9. Effect of potassium on the conformational state of the complex of ouabain with sodium- and potassium-dependent adenosine triphosphatase.
Akera T; Tobin T; Gatti A; Shieh IS; Brody TM
Mol Pharmacol; 1974 May; 10(3):509-18. PubMed ID: 4277460
[No Abstract] [Full Text] [Related]
10. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
Yoda A; Yoda S; Sarrif AM
Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
[No Abstract] [Full Text] [Related]
11. Ouabain binding to sodium- and potassium-dependent adenosine triphosphatase: inhibition by the , -methylene analogue of adenosine triphosphate.
Tobin T; Akera T; Hogg RE; Brody TM
Mol Pharmacol; 1973 Mar; 9(2):278-81. PubMed ID: 4268124
[No Abstract] [Full Text] [Related]
12. Association and dissociation rate constants of the complexes between various cardiac aglycones and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
Yoda A; Yoda S
Mol Pharmacol; 1977 Mar; 13(2):352-61. PubMed ID: 140301
[No Abstract] [Full Text] [Related]
13. Nucleotide specificity of the Na + -stimulated phosphorylation and ( 3 H)ouabain-binding reactions of (Na + + K + )-dependent adenosine triphosphatase.
Tobin T; Baskin SI; Akera T; Brody TM
Mol Pharmacol; 1972 Mar; 8(2):256-63. PubMed ID: 4260223
[No Abstract] [Full Text] [Related]
14. Calcium ion and sodium- and potassium-dependent adenosine triphosphatase: its mechanism of inhibition and identification of the E 1 -P intermediate.
Tobin T; Akera T; Baskin SI; Brody TM
Mol Pharmacol; 1973 May; 9(3):336-49. PubMed ID: 4267957
[No Abstract] [Full Text] [Related]
15. Irreversible inhibition of Na-+ +K-+ -ATPase by strophanthidin 3,5-bid-p-benzoyl benzoate, a photochemical analogue of strophanthidin.
Tobin T; Akera T; Brody TM; Taneja HR
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):605-18. PubMed ID: 125443
[TBL] [Abstract][Full Text] [Related]
16. The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain.
Akera T; Brody TM
Mol Pharmacol; 1969 Nov; 5(6):605-14. PubMed ID: 4244695
[No Abstract] [Full Text] [Related]
17. Inhibition of sodium- and potassium-dependent adenosine triphosphatase by N-ethylmaleimide. II. Effects of sodium-activated transphosphorylation.
Banerjee SP; Wong SM; Sen AK
Mol Pharmacol; 1972 Jan; 8(1):18-29. PubMed ID: 4258646
[No Abstract] [Full Text] [Related]
18. The role of phospholipids in the binding of ouabain to sodium- and potassium-dependent adenosine triphosphatase.
Taniguchi K; Iida S
Mol Pharmacol; 1973 May; 9(3):350-9. PubMed ID: 4267958
[No Abstract] [Full Text] [Related]
19. Dissociation of the positive inotropic action of digitalis from inhibition of sodium- and potassium-activated adenosine triphosphate.
Okita GT; Richardson F; Roth-Schechter BF
J Pharmacol Exp Ther; 1973 Apr; 185(1):1-11. PubMed ID: 4266379
[No Abstract] [Full Text] [Related]
20. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain.
Yoda A; Hokin LE
Biochem Biophys Res Commun; 1970 Aug; 40(4):880-6. PubMed ID: 4251204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
